Gene · 4929
Papers4,115
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,115
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection. | Molecules | 2022 | 36234768 | PubTator, text mining | PubMed |
| Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease. | Int J Mol Sci | 2022 | 36233355 | PubTator, text mining | PubMed |
| Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias. | Int J Mol Sci | 2022 | 36233161 | PubTator, text mining | PubMed |
| A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells. | Int J Mol Sci | 2022 | 36233051 | PubTator, text mining | PubMed |
| Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders. | Int J Mol Sci | 2022 | 36233034 | PubTator, text mining | PubMed |
| What Do the Transcriptome and Proteome of Menstrual Blood-Derived Mesenchymal Stem Cells Tell Us about Endometriosis? | Int J Mol Sci | 2022 | 36232817 | PubTator, text mining | PubMed |
| Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders. | Cells | 2022 | 36231058 | PubTator, text mining | PubMed |
| Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons. | Sci Rep | 2022 | 36229560 | PubTator, text mining | PubMed |
| Human papillomavirus integration perspective in small cell cervical carcinoma. | Nat Commun | 2022 | 36216793 | PubTator, text mining | PubMed |
| lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway. | Comput Math Methods Med | 2022 | 36213586 | PubTator, text mining | PubMed |
| Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy. | Front Immunol | 2022 | 36211355 | PubTator, text mining | PubMed |
| Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer. | Front Genet | 2022 | 36204323 | PubTator, text mining | PubMed |
| Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway. | Evid Based Complement Alternat Med | 2022 | 36193151 | PubTator, text mining | PubMed |
| microRNA-205 in prostate cancer: Overview to clinical translation. | Biochim Biophys Acta Rev Cancer | 2022 | 36191828 | PubTator, text mining | PubMed |
| IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient. | Clin Immunol | 2022 | 36189576 | PubTator, text mining | PubMed |
| Utilizing mast cells in a positive manner to overcome inflammatory and allergic diseases. | Front Immunol | 2022 | 36189267 | PubTator, text mining | PubMed |
| Alzheimer's disease: Pathophysiology and dental pulp stem cells therapeutic prospects. | Front Cell Dev Biol | 2022 | 36187488 | PubTator, text mining | PubMed |
| MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease. | Front Cell Neurosci | 2022 | 36187290 | PubTator, text mining | PubMed |
| Expression profiling suggests the involvement of hormone-related, metabolic, and Wnt signaling pathways in pterygium progression. | Front Endocrinol (Lausanne) | 2022 | 36187094 | PubTator, text mining | PubMed |
| LincRNA-p21 Upregulates Nuclear Orphan Receptor Nr4a2 and Aggravates Myocardial Ischemia/Reperfusion Injury via Targeting MiR-466i-5p. | Int Heart J | 2022 | 36184541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4929/papers?page=34